Angiogenesis Inhibitors: all 4,430 studies that test it
Page 36 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein OcclusionStatus unknownNCT01044329Phase 2
- Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal CancerCompletedNCT01043484Phase 2
- Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple MyelomaCompletedNCT01042704Phase 1
- Efficacy of PreOperative Bevacizumab for Diabetic Eye DiseaseCompletedNCT01041690Not applicable
- A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01038388Phase 1
- Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized RegimenCompletedNCT01037348Phase 2
- Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) PatientsTerminatedNCT01036399Phase 2
- Sunitinib in Metastatic Renal CancerCompletedNCT01034878Phase 2
- Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular DegenerationCompletedNCT01032109Not applicable
- Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:CompletedNCT01030770Phase 2/3
- Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With EndometriosisTerminatedNCT01028781Phase 1
- A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01028729Phase 4
- Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female VolunteersCompletedNCT01028261Phase 1
- Lucentis for Macular Edema Associated With Central Retinal Vein OcclusionCompletedNCT01028248Phase 1
- Ranibizumab in Patients With Branch Retinal Vein OcclusionCompletedNCT01027481Phase 4
- Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic RetinopathyCompletedNCT01025934Phase 4
- Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast CancerCompletedNCT01025349Phase 2
- Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
- Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01024205Phase 2
- Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable GlioblastomaCompletedNCT01022918Phase 2
- Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
- Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRICompletedNCT01020630Phase 2
- Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerStatus unknownNCT01019798Phase 2
- Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid StreaksWithdrawnNCT01015495Phase 1/2
- Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau DiseaseTerminatedNCT01015300Early Phase 1
- Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
- Bevacizumab Versus Ranibizumab in Age Related Macular DegenerationStatus unknownNCT01014468Phase 3
- Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein OcclusionStatus unknownNCT01011374Phase 1
- Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialStatus unknownNCT01010243Phase 1/2
- A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)TerminatedNCT01005979Phase 1
- Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT01005472Phase 1
- Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple MyelomaStatus unknownNCT01002703Phase 1/2
- A Study of Endostar Combined With Chemotherapy for Treatment of OsteosarcomaStatus unknownNCT01002092Phase 2
- Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular EdemaStatus unknownNCT00999791Phase 1
- Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)CompletedNCT00997191Phase 3
- Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)Status unknownNCT00993525Phase 1/2
- Bevacizumab for the Treatment of Corneal NeovascularizationStatus unknownNCT00992849Phase 2
- Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell LymphomaCompletedNCT00987493Phase 1/2
- Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00984438Phase 1/2
- Stereotactic Radiosurgery With Sunitinib for Brain MetastasesCompletedNCT00981890Phase 1
- Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)CompletedNCT00981708Phase 1/2
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic SyndromeTerminatedNCT00977132Phase 2
- Intravitreal Ranibizumab in Retinal Pigment Epithelial DetachmentsCompletedNCT00976222Phase 4
- A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00974584Phase 1
- S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by SurgeryStatus unknownNCT00974389Phase 2
- Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell LymphomaStatus unknownNCT00974324Phase 2
- Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)CompletedNCT00973609Phase 3
- Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)TerminatedNCT00972842Phase 1/2
- The Treatment of Lenalidomide in Patients With POEMS SyndromeStatus unknownNCT00971685Phase 2
- Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein OcclusionCompletedNCT00970957Phase 3
- Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain BirthmarksWithdrawnNCT00969397Phase 1/2
- Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT00968331Phase 2
- Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)CompletedNCT00968240Phase 1
- Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High MyopiaCompletedNCT00967850Phase 3
- Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerCompletedNCT00967603Phase 2
- Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular DegenerationCompletedNCT00967213Phase 3
- Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.CompletedNCT00963534Phase 1/2
- RMPT for Relapsed/Refractory Multiple MyelomaCompletedNCT00961467Phase 2
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast CancerCompletedNCT00960960Phase 1
- Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell LymphomaStatus unknownNCT00958854Phase 2
- Maintenance Therapy in Acute Myeloid Leukemia (AML) PatientsCompletedNCT00957385Phase 2
- A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer EarlyStatus unknownNCT00957125Phase 2
- Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis SyndromeStatus unknownNCT00955630Phase 1/2
- Sunitinib Malate in Treating Patients With Small Cell Lung CancerTerminatedNCT00953459Phase 2
- Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00952029Phase 2/3
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsCompletedNCT00952003Phase 2
- Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic StageCompletedNCT00949364Phase 2
- Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow MicrometastasesCompletedNCT00949247Early Phase 1
- Sunitinib Malate in Treating Patients With Kidney CancerCompletedNCT00943839Not applicable
- Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)CompletedNCT00942864Phase 3
- OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00940303Phase 2
- Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00936832Phase 2
- A Study of High-Risk Oral Cavity CancerTerminatedNCT00934739Phase 2/3
- Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple MyelomaCompletedNCT00934154Phase 3
- Lenalidomide and Paclitaxel in Prostate CancerTerminatedNCT00933426Phase 1
- Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00931450Phase 1/2
- Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy AloneStatus unknownNCT00931125Phase 2
- Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
- Bevacizumab and VasoconstrictionCompletedNCT00929058Not applicable
- Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) TypeStatus unknownNCT00923663Phase 2
- Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic SyndromesTerminatedNCT00923234Phase 1
- Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal CancerCompletedNCT00921661Phase 1
- Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular CarcinomaStatus unknownNCT00921531Phase 3
- A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent GliomasCompletedNCT00921167Phase 2
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple MyelomaCompletedNCT00915408Phase 1/2
- Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)CompletedNCT00912392Phase 2
- TC Avastin. ICORG 08-10, V6CompletedNCT00911716Not applicable
- Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer RectumCompletedNCT00909987Phase 2
- A Study of Bevacizumab to Prevent Malignant AscitesWithdrawnNCT00908219Phase 2
- Bevacizumab for Central Retinal Vein Occlusion StudyCompletedNCT00906685Phase 3
- Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT00906516Phase 2
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
- An Explorative Study on the Pharmacokinetics and Pharmacodynamics of Sunitinib in Healthy VolunteersCompletedNCT00904657Phase 1
- Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal FailureStatus unknownNCT00902915Phase 2
- Lenalidomide and R-CHOP in B-cell LymphomaCompletedNCT00901615Phase 1/2
- Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of RanibizumabCompletedNCT00892398Not applicable
- Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00891475Phase 1/2
- Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple MyelomaCompletedNCT00891384Phase 3